Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yamaguchi M et al. – Concurrent chemoradiotherapy using multidrug resistance–nonrelated agents and etoposide is a safe and effective treatment for localized nasal NK/T–cell lymphoma and warrants further investigation.

Related Articles

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
Blood, 10/13/09    Relevance Score: 97%

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for improving survival of lymphoma study
Journal of Clinical Oncology, 11/09/09    Relevance Score: 96%

When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type
Annals of Oncology, 10/29/09    Relevance Score: 96%

NK cell lymphoma
International Journal of Hematology, 10/12/09    Relevance Score: 96%

Primary cutaneous marginal zone lymphoma
Critical Reviews in Oncology/Hematology, 10/15/09    Relevance Score: 94%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address